Understanding the Market | MicroPort Medbot-B surged over 8% in the closing session, with strong order trends and surgical robots leading a new clinical transformation
MircroPort Medbot-B surged over 8% in the late trading session, as of the time of writing, it rose 8.23% to HKD 15.78, with a transaction volume of HKD 148 million. In terms of news, MicroPort Medbot previously released its annual performance, with a projected loss attributable to shareholders of HKD 642 million in 2024, a year-on-year narrowing of 36.5%. Morgan Stanley previously pointed out that MicroPort Medbot's order trend is strong, and it is expected that due to the rapid expansion of robot installations in China and overseas, the company's contribution to MicroPort Medical sales will increase from about 3% in 2024 to about 40% in 2033. Industrial Securities stated that due to the significant global market potential for surgical robots, along with a high customer stickiness and sustainable "equipment + consumables/services" business model, Intuitive Surgical enjoys a high valuation level in the U.S. stock market thanks to its market-leading innovative products, solid market share, and steady performance growth. It is recommended to pay attention to leading domestic surgical robot companies with product competitiveness and continuous innovation, such as MicroPort Medbot
According to Zhitong Finance APP, MicroPort Medbot-B (02252) rose over 8% in late trading, with a current increase of 8.23%, priced at HKD 15.78, and a trading volume of HKD 148 million.
On the news front, MicroPort Medbot previously released its annual performance, reporting a shareholder loss of RMB 642 million for 2024, a year-on-year narrowing of 36.5%. Morgan Stanley previously pointed out that MicroPort Medbot's order trend is strong, and it is expected that due to the rapid expansion of robot installations in China and overseas, the company's contribution to MicroPort Healthcare sales will increase from about 3% in 2024 to about 40% in 2033.
Industrial Securities stated that due to the significant global market potential for surgical robots, along with a highly sticky and sustainable "equipment + consumables/services" business model, Intuitive Surgical enjoys a high valuation level in the U.S. stock market thanks to its market-leading innovative products, solid market share, and stable performance. It is recommended to pay attention to leading domestic surgical robot companies with product competitiveness and continuous innovation, such as MicroPort Medbot